Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAPENTINE vs RILONACEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAPENTINE vs RILONACEPT: Safety Overview

Metric RIFAPENTINE RILONACEPT
Total FAERS Reports 298 843
Deaths Reported 8 14
Death Rate 2.7% 1.7%
Hospitalizations 88 65
Average Patient Age 46.5 yrs 51.9 yrs
% Female Patients 55.6% 68.2%
FDA Approval Date Jun 22, 1998 N/A
Manufacturer sanofi-aventis U.S. LLC Kiniksa Pharmaceuticals (UK), Ltd.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription